Atlas Trials

Neoadjuvant Pimicotinib Combined With Surgery Versus Upfront Surgery for Diffuse Tenosynovial Giant Cell Tumor

Clinical trial NCT07707882 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07707882
Sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Tenosynovial Giant Cell Tumor, Diffuse
Start date
2027-10-01
Primary completion
2029-09-30
Enrollment
84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.